Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting SMAD2

State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

More Information

Corresponding author: E-mail address: symlh2006@163.com (Yongmei Song)

These authors contributed equally to this work.

摘要

- /
- /
- /
Abstract: Esophageal squamous cell carcinoma (ESCC) is one of the most common and deadly cancers in the world. Currently, clinical therapy of ESCC remains limited and the five-year survival rate is poor. The function of miR-425 has been reported in multiple human cancers. However, the tumorigenic role and clinical significance of miR-425 in ESCC remains unclear. We found that enhanced expression of miR-425 in ESCC cell lines not only promoted cell proliferation and colony formation, but also increased cellular metastasis. Furthermore, we revealed the mechanism that miR-425 inhibited the expression of SMAD2 by targeting the second binding site in the 3′-untranslated region (3′-UTR) in ESCC. This mode of action influenced not only SMAD2 mRNA expression but also protein expression. In addition, we detected the expression of miR-425 in ESCC tissues and plasma. Moreover, we analyzed the relationship between miR-425 expression and SMAD2 mRNA expression. We found that miR-425 was overexpressed in ESCC tissues and the plasma relative to adjacent normal tissues and plasma of healthy individuals. Furthermore, there was a negative correlation between miR-425 expression and SMAD2. Taken together, our results show that miR-425 functions as an oncogene by targeting the 3′-UTR of SMAD2 and indicate the potential utility of plasma miR-425 as a novel biomarker for ESCC diagnosis.
- Esophageal squamous cell carcinoma /
- miR-425 /
- Plasma miRNA /
- SMAD2
These authors contributed equally to this work.
注释:

HTML全文

参考文献(20)

[1]	Boyd, S.D. Everything you wanted to know about small RNA but were afraid to ask Lab. Invest., 88 (2008),pp. 569-578
[2]	Cao, S., Xiao, L., Rao, J.N. et al. Inhibition of Smurf2 translation by miR-322/503 modulates TGF-beta/Smad2 signaling and intestinal epithelial homeostasis Mol. Biol. Cell, 25 (2014),pp. 1234-1243
[3]	Chen, M.Q., Xu, B.H., Zhang, Y.Y. Analysis of prognostic factors for esophageal squamous cell carcinoma with distant organ metastasis at initial diagnosis J. Chin. Med. Assoc., 77 (2014),pp. 562-566
[4]	Chen, Z., Li, J., Tian, L. et al. miRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma Cancer Lett., 350 (2014),pp. 34-42
[5]	Di Leva, G., Piovan, C., Gasparini, P. et al. Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status PLoS Genet., 9 (2013),p. e1003311
[6]	Jiang, F., Mu, J., Wang, X. et al. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells PLoS One, 9 (2014),p. e96698
[7]	Kanaan, Z., Rai, S.N., Eichenberger, M.R. et al. Plasma miR-21: a potential diagnostic marker of colorectal cancer Ann. Surg., 256 (2012),pp. 544-551
[8]	Komatsu, S., Ichikawa, D., Takeshita, H. et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma Expert Opin. Biol. Ther., 12 (2012),pp. S53-S59
[9]	Li, B.S., Zhao, Y.L., Guo, G. et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection PLoS One, 7 (2012),p. e41629
[10]	Ma, J., Liu, J., Wang, Z. et al. NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1beta induction Mol. Cancer, 13 (2014),p. 40
[11]	Mitchell, P.S., Parkin, R.K., Kroh, E.M. et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. USA, 105 (2008),pp. 10513-10518
[12]	Moustakas, A., Souchelnytskyi, S., Heldin, C.H. Smad regulation in TGF-beta signal transduction J. Cell Sci., 114 (2001),pp. 4359-4369
[13]	Peng, W.Z., Ma, R., Wang, F. et al. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer Int. J. Mol. Sci., 15 (2014),pp. 4031-4048
[14]	Qi, Y.J., Chao, W.X., Chiu, J.F. An overview of esophageal squamous cell carcinoma proteomics J. Proteomics, 75 (2012),pp. 3129-3137
[15]	Song, Y., Li, L., Ou, Y. et al. Identification of genomic alterations in oesophageal squamous cell cancer Nature, 509 (2014),pp. 91-95
[16]	Uemura, N., Kondo, T. Current advances in esophageal cancer proteomics Biochim. Biophys. Acta, 1854 (2015),pp. 687-695
[17]	Yamada, A., Cox, M.A., Gaffney, K.A. et al. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia PLoS One, 9 (2014),p. e112481
[18]	Yang, C., Ning, S., Li, Z. et al. miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion Cancer Cell Int., 14 (2014),p. 138
[19]	Yang, M., Liu, R., Li, X. et al. miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4 Mol. Cells, 37 (2014),pp. 873-880
[20]	Zhang, W., Yang, F., Zhan, Q. Dynamic analysis of DNA damage induced miRNAs in colon cancer cells Chinese Sci. Bull., 59 (2014),pp. 2254-2265